New insider Savage Brian claimed ownership of 739 units of Ordinary Shares (SEC Form 3)
$TEVA
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 02/11/2026 |
3. Issuer Name and Ticker or Trading Symbol
TEVA PHARMACEUTICAL INDUSTRIES LTD [ TEVA ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Ordinary Shares(1) | 739 | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (right to buy) | (2) | 03/17/2026 | Ordinary Shares(1) | 2,253 | $53.5 | D | |
| Stock Options (right to buy) | (3) | 03/03/2027 | Ordinary Shares(1) | 4,503 | $34.7 | D | |
| Restricted Share Units | (4) | (4) | Ordinary Shares(1) | 18,967 | (5) | D | |
| Restricted Share Units | (6) | (6) | Ordinary Shares(1) | 13,844 | (5) | D | |
| Restricted Share Units | (7) | (7) | Ordinary Shares(1) | 15,066 | (5) | D | |
| Restricted Share Units | (8) | (8) | Ordinary Shares(1) | 14,320 | (5) | D | |
| Explanation of Responses: |
| 1. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. |
| 2. Stock options were granted on March 17, 2016, with 563 vested on each of March 17, 2017, March 17, 2018 and March 17, 2019, and 564 vested on March 17, 2020. |
| 3. Stock options were granted on March 3, 2017, with 1,125 vested on each of March 3, 2018, March 3, 2019 and March 3, 2020, and 1,128 vested on March 3, 2021. |
| 4. Restricted share units were granted on March 4, 2022, with 4,741 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 4,744 vesting on March 4, 2026. |
| 5. Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 6. Restricted share units were granted on March 3, 2023, with 3,461 vested on each of March 3, 2024 and March 3, 2025, and 3,461 vesting on each of March 3, 2026 and March 3, 2027. |
| 7. Restricted share units were granted on March 4, 2024, with 3,766 vested on March 4, 2025, 3,766 vesting on each of March 4, 2026 and March 4, 2027, and 3,768 vesting on March 4, 2028. |
| 8. Restricted share units were granted on March 5, 2025, with 3,580 vesting on each of March 5, 2026, March 5, 2027, March 5, 2028 and March 5, 2029. |
| /s/ Dov Bergwerk as attorney-in-fact for Brian P. Savage | 02/23/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||